Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Alkermes (ALKS) Shares Issued (2016 - 2026)

Alkermes has reported Shares Issued over the past 16 years, most recently at $11.2 million for Q4 2025.

Quarterly Shares Issued rose 36.02% to $11.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.4 million through Dec 2025, up 57.45% year-over-year, with the annual reading at $43.4 million for FY2025, 57.45% up from the prior year.
Shares Issued was $11.2 million for Q4 2025 at Alkermes, up from $622000.0 in the prior quarter.
Over five years, Shares Issued peaked at $29.5 million in Q1 2025 and troughed at $509000.0 in Q4 2021.
The 5-year median for Shares Issued is $3.0 million (2023), against an average of $6.6 million.
Year-over-year, Shares Issued surged 439.0% in 2021 and then crashed 88.73% in 2025.
A 5-year view of Shares Issued shows it stood at $509000.0 in 2021, then soared by 53.24% to $780000.0 in 2022, then soared by 111.15% to $1.6 million in 2023, then surged by 398.97% to $8.2 million in 2024, then soared by 36.02% to $11.2 million in 2025.
Per Business Quant, the three most recent readings for ALKS's Shares Issued are $11.2 million (Q4 2025), $622000.0 (Q3 2025), and $2.1 million (Q2 2025).